Your browser doesn't support javascript.
loading
The PD-L1/4-1BB Bispecific Antibody-Anticalin Fusion Protein PRS-344/S095012 Elicits Strong T-Cell Stimulation in a Tumor-Localized Manner.
Peper-Gabriel, Janet K; Pavlidou, Marina; Pattarini, Lucia; Morales-Kastresana, Aizea; Jaquin, Thomas J; Gallou, Catherine; Hansbauer, Eva-Maria; Richter, Marleen; Lelievre, Helene; Scholer-Dahirel, Alix; Bossenmaier, Birgit; Sancerne, Celine; Riviere, Matthieu; Grandclaudon, Maximilien; Zettl, Markus; Bel Aiba, Rachida S; Rothe, Christine; Blanc, Veronique; Olwill, Shane A.
Afiliação
  • Peper-Gabriel JK; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.
  • Pavlidou M; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.
  • Pattarini L; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France.
  • Morales-Kastresana A; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.
  • Jaquin TJ; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.
  • Gallou C; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France.
  • Hansbauer EM; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.
  • Richter M; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.
  • Lelievre H; Institut de Recherches Internationales Servier Oncology R&D Unit, Suresnes, France.
  • Scholer-Dahirel A; Institut de Recherches Internationales Servier Oncology R&D Unit, Suresnes, France.
  • Bossenmaier B; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.
  • Sancerne C; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France.
  • Riviere M; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France.
  • Grandclaudon M; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France.
  • Zettl M; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.
  • Bel Aiba RS; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.
  • Rothe C; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.
  • Blanc V; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France.
  • Olwill SA; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.
Clin Cancer Res ; 28(15): 3387-3399, 2022 08 02.
Article em En | MEDLINE | ID: mdl-35121624
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígeno B7-H1 / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígeno B7-H1 / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article